Case File
efta-efta01840753DOJ Data Set 10CorrespondenceEFTA Document EFTA01840753
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01840753
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
EFTA DisclosureText extracted via OCR from the original document. May contain errors from the scanning process.
To
Fran:
e ey pstein
Sent
Mon 2/6/2012 10:53:58 PM
Subject Re: Hi Jeffrey
cambridge april 12, but phone availble before
On Mon, Feb 6, 2012 at 5:15 PM,
wrote:
Hi Jeffrey,
When is a good time to talk about placebo? When arc you next in Cambridge?
ted
Ted J. Kaptchuk
Associate Professor of Medicine
Harvard Medical School
Director, Program in Placebo Studies & Therapeutic Encounter
Beth Israel Deaconess Medical Center
On Jan 13, 2012, at 3:15 PM, Jeffrey Epstein wrote:
Im in africa until the 27th
On Fri, Jan 13, 2012 at 9:05 PM,
ted
wrote:
Hi Jeff,
Fm around Monday, Martin Luther King day until 3pm. Is that a good day for a
phone conversation?
Alternatively, as the phone hasn't been too successful, should we meet in person?
When are you in Cambridge next?
EFTA_R1_00225820
EFTA01840753
Ted J. Kaptchuk
Associate Professor of Medicine
Harvard Medical School
Director, Program in Placebo Studies & Therapeutic Encounter
Beth Israel Deaconess Medical Center
Boston. MA 02215
e : www.programinp ace os u ies.orq
On Dec 25, 2011, at 1:31 PM, Jeffrey Epstein wrote:
lets alk on tues
On Sun, Dec 25, 2011 at 2:04 PM,
wrote:
Is there a good time to check-in with you to get your feedback on
the budget we sent you two weeks ago and on what issues would
interest you in developing a partnership with our efforts in placebo
studies?
We're trying to think bot scientifically and strategically. Our team
has all the intellectual and infrastructure resources of Harvard
University and any input would be appreciated.
Best,
ted
Ted J. Kaptchuk
Associate Professor of Medicine
Harvard Medical School
Director, Program in Placebo Studies & Therapeutic Encounter
Beth Israel Deaconess Medical Center
Boston, MA 02215
EFTA_R1_00225821
EFTA01840754
Email
Web: www.programinplacebostudies.org
On Dec 5, 2011, at 2:41 PM, Jeffrey Epstein wrote:
now?
On Mon, Dec 5, 2011 at 1:26 PM, <a
wrote:
I tried calling you on November 28. No answer.
Our work is getting enormous media attention. (Attached is an article in this
week's New Yorker. I wished it had focused more on
our science and less on me. We expect coverage by
"60 Minutes" in January.)
This is a critical time to develop our scientific and institutional roots at
Harvard. We're looking for partners to help move
our research along. Would there be another time you
could talk by telephone?
Best
ted
Ted J. Kaptchuk
Associate Professor of Medicine
Harvard Medical School
Director, Program in Placebo Studies & Therapeutic Encounter
Beth Israel Deaconess Medical Center
Boston. MA 02215
Web: www.proerammplaccbostudies.org
EFTA_R1_00225822
EFTA01840755
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
**************************************
*********************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacationagmail.com and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00225823
EFTA01840756
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
*******
****** **************************
********************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return c-mail or by c-mail to jeevacati n
mail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00225824
EFTA01840757
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01846833
2p
DOJ Data Set 10OtherUnknown
EFTA01768150
9p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01770852
0p
DOJ Data Set 11OtherUnknown
EFTA02522800
5p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01873814
0p
DOJ Data Set 10CorrespondenceUnknown
EFTA Document EFTA01843924
0p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.